| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.9M | — | -40.8% |
| Cost of Revenue | $1.3M | — | -12.7% |
| Gross Profit | $581K | — | -65.6% |
| R&D Expense | $442K | — | -27.7% |
| SG&A Expense | $9.0M | — | -42.9% |
| Operating Income | -$8.8M | — | +39.6% |
| Pre-tax Income | -$10.1M | — | +48.8% |
| Income Tax | -$24K | — | -1100.0% |
| Net Income | -$10.1M | — | +49.0% |
| EPS (Basic) | -$0.16 | — | +69.2% |
| EPS (Diluted) | -$0.16 | — | +69.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.0M | -28.0% | -45.7% |
| Inventory | $1.2M | -18.5% | -5.9% |
| Current Assets | $2.9M | -57.2% | -24.9% |
| Total Assets | $32.7M | -11.8% | -12.2% |
| Current Liabilities | $25.2M | -9.2% | -11.2% |
| Long-term Debt | $6.3M | +1.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.8M | — | -412.4% |
| Financing Cash Flow | $1.8M | — | +64.6% |
| +73.1% |
| Total Liabilities | $28.1M | -25.1% | -30.4% |
| Stockholders' Equity | $4.7M | +1489.0% | +253.6% |